Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Transl Psychiatry ; 7(8): e1205, 2017 08 15.
Article in English | MEDLINE | ID: mdl-28809859

ABSTRACT

Major depressive disorder (MDD) is a heritable and highly debilitating condition. It is commonly associated with subcortical volumetric abnormalities, the most replicated of these being reduced hippocampal volume. Using the most recent published data from Enhancing Neuroimaging Genetics through Meta-analysis (ENIGMA) consortium's genome-wide association study of regional brain volume, we sought to test whether there is shared genetic architecture between seven subcortical brain volumes and intracranial volume (ICV) and MDD. We explored this using linkage disequilibrium score regression, polygenic risk scoring (PRS) techniques, Mendelian randomisation (MR) analysis and BUHMBOX. Utilising summary statistics from ENIGMA and Psychiatric Genomics Consortium, we demonstrated that hippocampal volume was positively genetically correlated with MDD (rG=0.46, P=0.02), although this did not survive multiple comparison testing. None of the other six brain regions studied were genetically correlated and amygdala volume heritability was too low for analysis. Using PRS analysis, no regional volumetric PRS demonstrated a significant association with MDD or recurrent MDD. MR analysis in hippocampal volume and MDD identified no causal association, however, BUHMBOX analysis identified genetic subgrouping in GS:SFHS MDD cases only (P=0.00281). In this study, we provide some evidence that hippocampal volume and MDD may share genetic architecture in a subgroup of individuals, albeit the genetic correlation did not survive multiple testing correction and genetic subgroup heterogeneity was not replicated. In contrast, we found no evidence to support a shared genetic architecture between MDD and other regional subcortical volumes or ICV.


Subject(s)
Brain/pathology , Depressive Disorder, Major/genetics , Depressive Disorder, Major/pathology , Adult , Aged , Cohort Studies , Female , Genetic Predisposition to Disease , Genome-Wide Association Study , Genotype , Hippocampus/pathology , Humans , Male , Middle Aged , United Kingdom
2.
Mol Psychiatry ; 21(3): 419-25, 2016 Mar.
Article in English | MEDLINE | ID: mdl-25754080

ABSTRACT

Cognitive impairment is common among individuals diagnosed with autism spectrum disorder (ASD) and attention-deficit hyperactivity disorder (ADHD). It has been suggested that some aspects of intelligence are preserved or even superior in people with ASD compared with controls, but consistent evidence is lacking. Few studies have examined the genetic overlap between cognitive ability and ASD/ADHD. The aim of this study was to examine the polygenic overlap between ASD/ADHD and cognitive ability in individuals from the general population. Polygenic risk for ADHD and ASD was calculated from genome-wide association studies of ASD and ADHD conducted by the Psychiatric Genetics Consortium. Risk scores were created in three independent cohorts: Generation Scotland Scottish Family Health Study (GS:SFHS) (n=9863), the Lothian Birth Cohorts 1936 and 1921 (n=1522), and the Brisbane Adolescent Twin Sample (BATS) (n=921). We report that polygenic risk for ASD is positively correlated with general cognitive ability (beta=0.07, P=6 × 10(-7), r(2)=0.003), logical memory and verbal intelligence in GS:SFHS. This was replicated in BATS as a positive association with full-scale intelligent quotient (IQ) (beta=0.07, P=0.03, r(2)=0.005). We did not find consistent evidence that polygenic risk for ADHD was associated with cognitive function; however, a negative correlation with IQ at age 11 years (beta=-0.08, Z=-3.3, P=0.001) was observed in the Lothian Birth Cohorts. These findings are in individuals from the general population, suggesting that the relationship between genetic risk for ASD and intelligence is partly independent of clinical state. These data suggest that common genetic variation relevant for ASD influences general cognitive ability.


Subject(s)
Attention Deficit Disorder with Hyperactivity/etiology , Autism Spectrum Disorder/complications , Autism Spectrum Disorder/genetics , Cognition Disorders/etiology , Multifactorial Inheritance/genetics , Polymorphism, Single Nucleotide/genetics , Adolescent , Adult , Attention Deficit Disorder with Hyperactivity/genetics , Autism Spectrum Disorder/epidemiology , Cohort Studies , Databases, Factual/statistics & numerical data , Family Health , Female , Genome-Wide Association Study , Humans , Intelligence Tests , Linear Models , Male , Risk Factors , Scotland , Severity of Illness Index , Young Adult
3.
Transl Psychiatry ; 5: e592, 2015 Jun 30.
Article in English | MEDLINE | ID: mdl-26125155

ABSTRACT

Major depressive disorder (MDD) and obesity are frequently co-morbid and this correlation is partly due to genetic factors. Although specific genetic risk variants are associated with body mass index (BMI) and with larger effect sizes in depressed individuals, the genetic overlap and interaction with depression has not been addressed using whole-genome data. Polygenic profile scores for MDD and BMI were created in 13,921 members of Generation Scotland: the Scottish Family Health Study and tested for their association with BMI, MDD, neuroticism and scores on the General Health Questionnaire (GHQ) (current psychological distress). The association between BMI polygenic profile scores and BMI was tested fitting GHQ, neuroticism or MDD status as an interaction term to test for a moderating effect of mood disorder. BMI polygenic profile scores were not associated with lifetime MDD status or neuroticism although a significant positive association with GHQ scores was found (P = 0.0001, ß = 0.034, r(2) = 0.001). Polygenic risk for MDD was not associated with BMI. A significant interaction between BMI polygenic profile scores and MDD (P = 0.0003, ß = 0.064), GHQ (P = 0.0005, ß = 0.027) and neuroticism (P = 0.003, ß = 0.023) was found when BMI was the dependent variable. The effect of BMI-increasing alleles was greater in those with MDD, high neuroticism or current psychological distress. MDD, neuroticism and current psychological distress amplify the effect of BMI polygenic profile scores on BMI. Depressed individuals with a greater polygenic load for obesity are at greater risk of becoming obese than control individuals.


Subject(s)
Depressive Disorder, Major/genetics , Obesity/genetics , Stress, Psychological/genetics , Adult , Anxiety Disorders , Body Mass Index , Comorbidity , Depressive Disorder, Major/epidemiology , Female , Genetic Predisposition to Disease , Genotype , Humans , Male , Middle Aged , Multifactorial Inheritance/genetics , Neuroticism , Obesity/epidemiology , Risk Factors , Stress, Psychological/epidemiology
4.
Eur J Pain ; 16(7): 1053-63, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22337623

ABSTRACT

Chronic pain is pathological, persisting beyond normal tissue healing time. Previous work has suggested ∼50% variation in chronic pain development is heritable. No data are currently available on the heritability of pain categorized using the Chronic Pain Grade (CPG). Furthermore, few existing studies have accounted for potential confounders that may themselves be under genetic control or indeed 'heritable' non-genetic traits. This study aimed to determine the relative contributions of genetic, measured and shared environmental and lifestyle factors to chronic pain. Chronic pain status was determined and CPG measured in participants from Generation Scotland: the Scottish Family Health Study, a large cohort of well-characterized, extended families from throughout Scotland, UK. Heritability estimates (h (2) ) for 'any chronic pain' and 'severe' chronic pain (CPG 3 or 4) were generated using SOLAR software, with and without adjustment for shared household effects and measured covariates age, body mass index, gender, household income, occupation and physical activity. Data were available for 7644 individuals in 2195 extended families. Without adjustment, h (2) for 'any chronic pain' was 29% [standard errors (SE) 6%; p < 0.001], and for 'severe' chronic pain was 44% (SE 3%; p <0.001). After adjustment, 'any chronic pain' h(2) = 16% (SE 7%; p = 0.02) and 'severe' chronic pain h(2) = 30% (SE 13%; p = 0.007). Co-heritability of both traits was 11% (SE 76%). This study supports the use of chronic pain as a phenotype in genetic studies, with adequate correction for confounders to specifically identify genetic risk factors for chronic pain.


Subject(s)
Chronic Pain/genetics , Quantitative Trait, Heritable , White People/genetics , Adult , Chronic Pain/diagnosis , Family , Female , Humans , Male , Middle Aged , Pain Measurement , Phenotype , Severity of Illness Index
6.
Biochem Soc Trans ; 32(Pt 5): 728-30, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15493999

ABSTRACT

Mutations affecting the UBA (ubiquitin-associated) domain of SQSTM1 (Sequestosome 1) (p62) are a common cause of Paget's disease of bone. The missense mutations resolve into those which retain [P392L (Pro(392)-->Leu), G411S] or abolish (M404V, G425R) the ability of the isolated UBA domain to bind Lys-48-linked polyubiquitin. These effects can be rationalized with reference to the solution structure of the UBA domain, which we have determined by NMR spectroscopy. The UBA domain forms a characteristic compact three-helix bundle, with a hydrophobic patch equivalent to that previously implicated in ubiquitin binding by other UBA domains. None of the mutations affect overall folding of the UBA domain, but both M404V and G425R involve residues in the hydrophobic patch, whereas Pro-392 and Gly-411 are more remote. A simple model assuming the isolated UBA domain is functioning as a compact monomer can explain the effects of the mutations on polyubiquitin binding. The P392L and G411S mutations do however have subtle local effects on secondary structure, which may become more relevant in full-length SQSTM1. Identification of the in vivo ubiquitylated substrates of SQSTM1 will be most informative in determining the functional significance of the SQSTM1-ubiquitin interaction, and consequences of the disease-associated mutations.


Subject(s)
Mutation , Osteitis Deformans/genetics , Proteins/chemistry , Proteins/genetics , Adaptor Proteins, Signal Transducing , Glycine/chemistry , Humans , Magnetic Resonance Spectroscopy , Mutation, Missense , Polyubiquitin/chemistry , Proline/chemistry , Protein Folding , Protein Structure, Tertiary , Proteins/physiology , Sequestosome-1 Protein , Structure-Activity Relationship , Ubiquitin/chemistry
7.
Calcif Tissue Int ; 75(5): 347-57, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15365659

ABSTRACT

Mutations in the Sequestosome 1 gene ( SQSTM1; also known as p62) have recently been identified as the cause of 5q35-linked Paget's disease of bone (PDB). All of the mutations identified to date affect the ubiquitin-associated (UBA) domain of SQSTM1, a region of the protein that binds noncovalently to ubiquitin. In this review we consider the possible functional significance of the SQSTM1-ubiquitin interaction, and consequences of the SQSTM1 UBA domain mutations. Clarification of the in vivo roles of SQSTM1 in bone-cell function will be central to improving our understanding of the molecular pathogenesis of PDB and related conditions.


Subject(s)
Osteitis Deformans/genetics , Proteins , DNA Mutational Analysis , Humans , Models, Biological , Models, Molecular , Mutation , Protein Structure, Tertiary , Proteins/chemistry , Proteins/metabolism , Ubiquitin/chemistry
8.
Am J Hum Genet ; 69(5): 1055-61, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11555792

ABSTRACT

Paget disease of bone (PDB) is a common disorder characterized by focal abnormalities of increased and disorganized bone turnover. Genetic factors are important in the pathogenesis of PDB, and previous studies have shown that the PDB-like bone dysplasia familial expansile osteolysis is caused by activating mutations in the TNFRSF11A gene that encodes receptor activator of nuclear factor kappa B (RANK); however, linkage studies, coupled with mutation screening, have excluded involvement of RANK in the vast majority of patients with PDB. To identify other candidate loci for PDB, we conducted a genomewide search in 319 individuals, from 62 kindreds with familial PDB, who were predominantly of British descent. The pattern of inheritance in the study group as a whole was consistent with autosomal dominant transmission of the disease. Parametric multipoint linkage analysis, under a model of heterogeneity, identified three chromosomal regions with LOD scores above the threshold for suggestive linkage. These were on chromosomes 2q36 (LOD score 2.7 at 218.24 cM), 5q35 (LOD score 3.0 at 189.63 cM), and 10p13 (LOD score 2.6 at 41.43 cM). For each of these loci, formal heterogeneity testing with HOMOG supported a model of linkage with heterogeneity, as opposed to no linkage or linkage with homogeneity. Two-point linkage analysis with a series of markers from the 5q35 region in another large kindred with autosomal dominant familial PDB also supported linkage to the candidate region with a maximum LOD score of 3.47 at D5S2034 (187.8 cM). These data indicate the presence of several susceptibility loci for PDB and identify a strong candidate locus for the disease, on chromosome 5q35.


Subject(s)
Chromosome Mapping , Chromosomes, Human, Pair 10/genetics , Chromosomes, Human, Pair 2/genetics , Chromosomes, Human, Pair 5/genetics , Genetic Heterogeneity , Osteitis Deformans/genetics , Female , Genome, Human , Glycoproteins/genetics , Humans , Lod Score , Male , Osteoprotegerin , Pedigree , Receptors, Cytoplasmic and Nuclear/genetics , Receptors, Tumor Necrosis Factor
SELECTION OF CITATIONS
SEARCH DETAIL
...